One of medicine's greatest challenges today is the efficient, seamless and safe translation of biomedicalresearch discoveries into clinical applications that improve human health. New methodologies, technologiesand integrated information systems offer unprecedented promise for discovery and growth of translationalsuccesses; however significant barriers continue to confound our ability to rapidly move discoveries intoclinical practice, including the efficiency, cost and effectiveness of our research processes. The ColoradoClinical and Translational Sciences Institute (CCTSl), created in 2008, has addressed these challenges andtransformed our institutional research infrastructure. In this application, the University of Colorado Denver(CU-D) and our partner institutions (CU-Boulder and Colorado State University [CSU], six major hospitalsand health care organizations and local communities) will re-engineer the CCTSl through the following fiveStrategic Goals: 1) Enrich and expand our integrated statewide academic home for clinicaland translationalresearch. 2) Institute new clinical research management strategies to strengthen quality, safety, efficiency,cost effectiveness and innovative team science, including implementing new software systems and workflows. 3) Centralize and enhance the delivery of our outstanding resources, services and technologies andinstitute charge-backs to investigators where appropriate. 4) Infuse key concepts of community engagementinto the full spectrum of translational research. 5) Increase the translational research workforce capacitythrough a broad curriculum of education, training and career development opportunities. A rigorous tracking,assessment and evaluation program coupled to a formal quality and process improvement programembedded in the CCCTSl will ensure the most efficient, cost-effective, and innovative use of our preciousresources, while protecting the safety of our study participants. These programs will be centralized at one ofthe newest biomedical research, education and clinical enterprises in the nation, the CU Anschutz MedicalCampus in which adjacencies of our schools, research laboratories, three hospitals and a biomedicalcorporate park create the ideal environment for our success.

Public Health Relevance

The relevance of this project to public health lies in our ability to help researchers take important discoveriesand translate them into new treatments, preventions and cures for human diseases. We also will helpresearchers find ways to bring these therapies into the community setting to benefit people across our stateand country.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Mentored Career Development Award (KL2)
Project #
1KL2TR001080-01
Application #
8720915
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Purucker, Mary E
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2013-09-26
Budget End
2014-04-30
Support Year
1
Fiscal Year
2013
Total Cost
$314,021
Indirect Cost
$15,035
Name
University of Colorado Denver
Department
Pediatrics
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Jeong, Mark Y; Lin, Ying H; Wennersten, Sara A et al. (2018) Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. Sci Transl Med 10:
Holden, Samantha K; Finseth, Taylor; Sillau, Stefan H et al. (2018) Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort. Mov Disord Clin Pract 5:47-53
Wang, Yang; Sosinowski, Tomasz; Novikov, Andrey et al. (2018) C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes. Proc Natl Acad Sci U S A 115:162-167
Aschner, Yael; Downey, Gregory P (2018) The Importance of Tyrosine Phosphorylation Control of Cellular Signaling Pathways in Respiratory Disease: pY and pY Not. Am J Respir Cell Mol Biol 59:535-547
Fox, Robert J; Coffey, Christopher S; Conwit, Robin et al. (2018) Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. N Engl J Med 379:846-855
Reisdorph, Nichole; Armstrong, Michael; Powell, Roger et al. (2018) Quantitation of peptides from non-invasive skin tapings using isotope dilution and tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1084:132-140
Rovner, Polina; Keltz, Julia; Allshouse, Amanda et al. (2018) Induction of the LH Surge in Premenarchal Girls Confirms Early Maturation of the Hypothalamic-Pituitary-Ovarian Axis. Reprod Sci 25:33-38
Elder, Alan M; Tamburini, Beth A J; Crump, Lyndsey S et al. (2018) Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer. Cancer Res 78:6473-6485
Trexler, Christa L; Odell, Aaron T; Jeong, Mark Y et al. (2017) Transcriptome and Functional Profile of Cardiac Myocytes Is Influenced by Biological Sex. Circ Cardiovasc Genet 10:
Brown, Laura D; Kohn, Jaden R; Rozance, Paul J et al. (2017) Exogenous amino acids suppress glucose oxidation and potentiate hepatic glucose production in late gestation fetal sheep. Am J Physiol Regul Integr Comp Physiol 312:R654-R663

Showing the most recent 10 out of 104 publications